SSY Group Ltd

02005

Company Profile

  • Business description

    SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

  • Contact

    Central Plaza, 18 Harbour Road
    Rooms 4902-03, 49th Floor
    Wanchai
    Hong Kong
    HKG

    T: +852 26880869

    http://www.ssygroup.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    6,100

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,023.3056.600.63%
CAC 407,857.3656.480.72%
DAX 4024,217.37247.011.03%
Dow JONES (US)44,632.99204.57-0.46%
FTSE 1009,136.3254.880.60%
HKSE25,473.4051.05-0.20%
NASDAQ21,098.2980.29-0.38%
Nikkei 22540,682.147.590.02%
NZX 50 Index12,961.2824.870.19%
S&P 5006,370.8618.91-0.30%
S&P/ASX 2008,764.1059.500.68%
SSE Composite Index3,632.4122.700.63%

Market Movers